ERBB2 and neoplasm: The ZJU Subtype 1 features recurrent TP53 mutation, ERBB2 amplification, and high tumor mutation burden (TMB)/tumor neoantigen burden (TNB) and exhibits intratumoral heterogeneity and liver metastasis tendency.